Efficacy of combined androgen blockade with zoledronic acid treatment in prostate cancer with bone metastasis: The Zoledronic Acid/Androgen Blockade Trial on Prostate Cancer (Zabton-PC) study

被引：1
|
作者：
Ueno, Satoru
Mizokami, Atsushi
Fukagai, Takashi
Fujimoto, Naohiro
Ohoka, Hitoshi
Kondo, Yukihiro
Arai, Gaku
Ide, Hisamitsu
Namiki, Mikio
机构：
[1] Kanazawa Univ, Grad Sch Med Sci, Kanazawa, Ishikawa, Japan
[2] Showa Univ, Sch Med, Tokyo 142, Japan
[3] Univ Occupat & Environm Hlth, Kitakyushu, Japan
[4] Kobe Med Ctr, Natl Hosp Org, Kobe, Hyogo, Japan
[5] Nippon Med Sch, Dept Urol, Tokyo 113, Japan
[6] Dokkyo Med Univ, Koshigaya Hosp, Saitama, Japan
[7] Teikyo Univ Hosp, Tokyo, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 04期
关键词：
D O I：
10.1200/jco.2014.32.4_suppl.207
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
207
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Maximal androgen blockade for advanced prostate cancer
    Mukha, Rajiv Paul
    Kumar, Santosh
    Kekre, N. S.
    INDIAN JOURNAL OF UROLOGY, 2010, 26 (01) : 133 - 138
  • [42] Maximum androgen blockade in advanced prostate cancer
    Wirth, M
    FORTSCHRITTE IN DIAGNOSTIK UND THERAPIE DES PROSTATAKARZINOMS, 1997, 5 : 59 - 66
  • [43] TOTAL ANDROGEN BLOCKADE FOR METASTATIC CANCER OF THE PROSTATE
    BELAND, G
    ELHILALI, M
    FRADET, Y
    LAROCHE, B
    RAMSEY, EW
    TRACHTENBERG, J
    VENNER, PM
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1988, 11 : S187 - S190
  • [44] TOTAL ANDROGEN BLOCKADE FOR METASTATIC CANCER OF PROSTATE
    BELAND, G
    ELHILALLI, MM
    FRADET, Y
    LAROCHE, B
    RAMSEY, EW
    TRACHTENBERG, J
    VENNER, PN
    JOURNAL OF UROLOGY, 1987, 137 (04): : A254 - A254
  • [45] Maximal androgen blockade for advanced prostate cancer
    Klotz, Laurence
    BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2008, 22 (02) : 331 - 340
  • [46] Combined androgen blockade for prostate cancer: Review of efficacy, safety and cost-effectiveness
    Akaza, Hideyuki
    CANCER SCIENCE, 2011, 102 (01) : 51 - 56
  • [47] The effect of combined androgen blockade on bone turnover and bone mineral density in men with prostate cancer
    Yamada, Y.
    Takahashi, S.
    Fujimura, T.
    Nishimatsu, H.
    Ishikawa, A.
    Kume, H.
    Tomita, K.
    Takeuchi, T.
    Kitamura, T.
    OSTEOPOROSIS INTERNATIONAL, 2008, 19 (03) : 321 - 327
  • [48] Weekly docetaxel, zoledronic acid, and estramustine in metastatic androgen-independent prostate cancer (MAIP)
    不详
    EUROPEAN UROLOGY SUPPLEMENTS, 2005, 4 (03) : 251 - 251
  • [49] The effect of combined androgen blockade on bone turnover and bone mineral density in men with prostate cancer
    Y. Yamada
    S. Takahashi
    T. Fujimura
    H. Nishimatsu
    A. Ishikawa
    H. Kume
    K. Tomita
    T. Takeuchi
    T. Kitamura
    Osteoporosis International, 2008, 19 : 321 - 327
  • [50] A phase III, multicenter, randomized, controlled study of maximum androgen blockade with versus without zoledronic acid in treatment-naive prostate cancer patients with bone metastases: Results of ZAPCA study.
    Kamba, Tomomi
    Kamoto, Toshiyuki
    Shimizu, Yousuke
    Namiki, Shunichi
    Fujimoto, Kiyohide
    Kawanishi, Hiroaki
    Sato, Fuminori
    Narita, Shintaro
    Satoh, Takefumi
    Saito, Hideo
    Sugimoto, Mikio
    Teishima, Jun
    Masumori, Naoya
    Egawa, Shin
    Sakai, Hideki
    Okada, Yusaku
    Terachi, Toshiro
    Ogawa, Osamu
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (07)
12345